Profile data is unavailable for this security.
About the company
Getein Biotech Inc is a China-based company mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and instruments. Its in vitro diagnostic reagents include Point-of-care Testing (POCT) reagents, chemiluminescence reagents, biochemical reagents, blood cell reagents, hemagglutination reagents and others. Its diagnostic instruments include immunoquantitative analyzer FIA 8000, immunoquantitative analyzer FIA 8600, fluorescence immunoquantitative analyzer Getein 1100, fluorescence immunoquantitative analyzer Getein 1180, automatic biochemical analyzer CM 400, automatic chemiluminescence analyzer MAGICL 6000 and five classification blood cell analyzer BHA-5000, among others. The Company also provides testing and agency services. The Company distributes its products within domestic market and to overseas markets.
- Revenue in CNY (TTM)1.25bn
- Net income in CNY252.99m
- Incorporated2002
- Employees2.14k
- LocationGetein Biotech IncNo. 9, Bofu Road, Yanjiang IndustrialDevelopment Zone, Liuhe DistrictNANJING 211505ChinaCHN
- Phone+86 2 568568577
- Fax+86 2 568568577
- Websitehttps://www.getein.com.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Well Lead Medical Co Ltd | 1.47bn | 215.29m | 4.14bn | 2.62k | 19.10 | 2.25 | -- | 2.82 | 0.7402 | 0.7402 | 5.06 | 6.27 | 0.5762 | 4.68 | 7.77 | 561,039.90 | 8.81 | 8.25 | 10.56 | 10.17 | 44.37 | 43.45 | 15.29 | 13.04 | 1.49 | 239.62 | 0.2318 | 51.11 | 1.79 | 13.22 | 15.56 | 24.10 | 35.39 | 45.41 |
| Goodwill E-Health Info Co Ltd | 633.21m | -16.79m | 4.22bn | 2.05k | -- | 2.36 | -- | 6.67 | -0.1239 | -0.1239 | 4.59 | 12.99 | 0.2472 | 0.5443 | 0.7415 | 308,883.90 | -1.28 | 1.28 | -1.78 | 1.95 | 49.21 | 50.60 | -5.18 | 3.48 | 1.75 | -2.75 | 0.1473 | 0.00 | -3.04 | 22.09 | -37.53 | -- | 66.10 | -- |
| SWS Hemodialysis Care Co Ltd | 532.45m | 74.82m | 4.32bn | 881.00 | 57.67 | 2.55 | -- | 8.11 | 0.233 | 0.233 | 1.66 | 5.27 | 0.2759 | 1.86 | 4.66 | 604,373.60 | 3.72 | -- | 4.02 | -- | 46.37 | -- | 13.47 | -- | 10.93 | -- | 0.016 | -- | 80.65 | -- | 228.34 | -- | -- | -- |
| Getein Biotech Inc | 1.25bn | 252.99m | 4.55bn | 2.14k | 17.98 | 1.75 | -- | 3.65 | 0.4988 | 0.4988 | 2.46 | 5.12 | 0.3241 | 1.62 | 2.91 | 584,007.90 | 6.73 | 13.25 | 9.86 | 18.45 | 67.64 | 65.57 | 20.76 | 28.13 | 1.69 | -- | 0.205 | 29.88 | -24.85 | 14.81 | -43.92 | 2.31 | 18.44 | 6.00 |
| Qingdao NovelBeam Technology Co Ltd | 413.02m | 124.91m | 4.79bn | 797.00 | 38.25 | 3.74 | -- | 11.59 | 1.04 | 1.04 | 3.44 | 10.63 | 0.2962 | 0.8663 | 4.68 | 518,221.70 | 8.81 | 14.67 | 9.37 | 16.63 | 63.85 | 62.32 | 29.73 | 34.15 | 9.12 | -- | 0.0262 | 33.55 | -1.31 | 18.58 | -20.19 | 21.71 | 10.45 | -- |
| Sino Medical Sciences Technology Inc | 417.13m | -4.63m | 4.81bn | 652.00 | -- | 5.61 | -- | 11.53 | -0.0112 | -0.0112 | 1.01 | 2.07 | 0.3498 | 1.45 | 33.50 | 639,765.50 | -0.3445 | -4.21 | -0.411 | -4.71 | 60.22 | 70.96 | -0.985 | -15.76 | 1.61 | -- | 0.1327 | -- | 77.99 | -2.04 | 75.59 | -- | -7.30 | -- |
| Jiangsu Bioperfectus Technologies Co Ltd | 394.84m | -170.68m | 4.82bn | 684.00 | -- | 1.47 | -- | 12.20 | -2.91 | -2.91 | 6.74 | 58.00 | 0.097 | 0.9747 | 2.52 | 577,244.10 | -4.19 | 25.41 | -4.74 | 31.26 | 65.70 | 63.37 | -43.23 | 32.86 | 4.96 | -- | 0.0903 | 30.54 | -92.72 | 11.81 | -120.45 | -- | 2.43 | -- |
| Holder | Shares | % Held |
|---|---|---|
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 2.83m | 0.56% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2024 | 1.53m | 0.30% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2024 | 814.37k | 0.16% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 695.19k | 0.14% |
| SSgA Funds Management, Inc.as of 03 Oct 2024 | 579.63k | 0.11% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2024 | 351.83k | 0.07% |
| Huachuang Securities Co. Ltd. (Investment Management)as of 30 Jun 2024 | 320.00k | 0.06% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 287.79k | 0.06% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 208.70k | 0.04% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 132.48k | 0.03% |
